The Federal Trade Commission has filed an injuction in federal court seeking to block Amgen’s acquisition of fellow drugmaker Horizon Therapeutics.
Read the full post on Becker's Hospital Review - Healthcare News
FTC sues to block $28M Amgen-Horizon deal
